Adaptive Biotechnologies Corp at JPMorgan Healthcare Conference (Virtual) Transcript
All right. Good afternoon. We're going to go ahead and take it off. I'm Tycho Peterson from the life science team. It's my pleasure to introduce our next company this afternoon, Adaptive Biotechnologies.
For those that want to submit a question, there is a link on the website. And with that, let me turn it over to Chad.
Hey, thanks, Tycho. And thank you to JPMorgan for the opportunity to present today. I want to wish everyone a happy and healthy 2021.
Obviously, 2020 was a challenging year, but what it do is it put the world on notice about the importance of the adaptive immune system. And that's been really our sole focus at Adaptive for the last decade. And as we start the new year, start the second decade of Adaptive, we're poised to execute on our platform to power the age of immune medicine.
So as we briefly move to Slide 2, a quick reminder, this presentation
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |